Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding
author
statement of authorship
T.Päll, A.Gad, L.Kasak, M.Drews, S.Strömblad, P.Kogerman
source
journal volume number month
23
year of publication
pages
47, p. 7874-7881
subject term
language
inglise
Päll, T., Gad, A., Kasak, L., Drews, M., Strömblad, S., Kogerman, P. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding // Oncogene (2004) 23, 47, p. 7874-7881.